Genomic sequence of HIV type 1 from four members of the sydney blood bank cohort of long-term nonprogressors

AIDS Research and Human Retroviruses

Volumn 14, Issue 9, 1998, Pages 811-814

  Oelrichs, Robert ^a   Tsykin, Anna ^a   Rhodes, David ^a   Solomon, Ajantha ^a   Ellett, Anne ^a   McPhee, Dale ^a   Deacon, Nicholas ^a  

^a Macfarlane Burnet Centre for Medical Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD BANK; CASE REPORT; COHORT ANALYSIS; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; VIRUS GENOME;

EID: 0032503585     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.811     Document Type: Article

References (11)

1. Learmont J, Tindall B, Evans L, Cunningham A, Cunningham P, Wells J, Penny R, Kaldor J, and Cooper DA: Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992;340:863-867.
2. Learmont J, Cook L, Dunckley H, and Sullivan J: Update on long-term symptomless HIV-1 infection in recipients of blood products from a single donor. AIDS Res Hum Retroviruses 1995; 11(1):1.
3. Deacon N, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker D, McPhee D, Greenway A, Ellett A, Chatfield C, Lawson V, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan J, Cunningham A, Dwyer D, Dowton D, and Mills J: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270(5238):988-991.
4. Daniel M, Kirchhoff F, Czajak S, Sehgal P, and Desrosiers R: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258(5090):1938-1941.
5. Igarashi T, Ami Y, Yamamoto H, Shibata R, Kuwata T, Mukai R, Shinohara K, Komatsu T, Adachi A, and Hayami M: Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: A potential candidate live-attenuated human AIDS vaccine. J Gen Virol 1997;78(Pt. 5):985-989.
6. Hirt B: Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 1967;36:365-369.
7. Oelrichs R, Coates Fryer K, Deacon N, Land S, Chatfield C, and McPhee D: Biological characterisation and full-length genomic sequence of two Australian primary isolates of HIV-1.1998 (in preparation).
8. Myers G, Hahan B, Mellors J, Henderson L, Korber B, Jeang K, McCutchan F, and Pavlakis G (eds.): Human Retroviruses and AIDS Database Compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, 1997. http://hiv-web.lanl.gov.
9. Schwartz S, Felber B, Fenyö E, and Pavlakis G: Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J Virol 1990;64(11):5448-5456.
10. Purcell D and Martin M: Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 1993;67(11):6365-6378.
11. Smith J, Azad A, and Deacon N: Identification of two novel human immunodeficiency virus type 1 splice acceptor sites in infected T cell lines. J Gen Virol 1992;73(Pt. 7):1825-1828.